TXG · 10x Genomics, Inc. · Executive Compensation
$58.19
-0.91 (-1.54%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.65B
Shares
131.53M
Volume · Nov 13
2.13M
Avg daily vol (3M)
3.35M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $6,329,244 |
| Eric S. Whitaker | Former Chief Legal Officer | $3,441,571 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $2,604,759 |
| Adam S. Taich | Chief Financial Officer | $2,233,107 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $7,929,349 |
| Eric S. Whitaker | Chief Legal Officer | $6,995,622 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $4,270,066 |
| Adam S. Taich | Chief Financial Officer | $3,296,235 |
| Justin McAnear | Former Chief Financial Officer | $3,037,877 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $8,286,049 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $4,425,630 |
| Eric S. Whitaker | Chief Legal Officer | $3,878,802 |
| Justin McAnear | Former Chief Financial Officer | $3,306,950 |
| James L. Wilbur | Former Chief Commercial Officer | $1,928,957 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $18,805,294 |
| Eric S. Whitaker | Chief Legal Officer | $11,903,680 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $9,869,889 |
| James L. Wilbur | Former Chief Commercial Officer | $8,892,052 |
| Justin McAnear | Former Chief Financial Officer | $6,842,330 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $11,700,985 |
| Eric S. Whitaker | Chief Legal Officer | $5,488,931 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $5,479,931 |
| Justin McAnear | Chief Financial Officer | $4,457,553 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ruth De Backer | Chief Business Officer | $10,971,399 |
| Serge Saxonov | Chief Executive Officer | $10,882,717 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $6,515,511 |
| Eric S. Whitaker | Chief Legal Officer | $5,847,185 |
| Bradford J. Crutchfield | Chief Commercial Officer | $4,283,649 |
| Justin McAnear | Chief Financial Officer | $4,263,816 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | $2,362,962 |
| Benjamin J. Hindson | President and Chief Scientific Officer | $1,669,186 |
| Eric S. Whitaker | General Counsel | $1,473,020 |
| Justin McAnear | Chief Financial Officer | $648,311 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Justin McAnear | Chief Financial Officer | $1,526,855 |
| Serge Saxonov | Chief Executive Officer | $1,084,275 |
| Eric S. Whitaker | General Counsel | $874,783 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mr. Gilliam | Chair of the Audit Committee of the Board of Directors | Appointed | 2026-11-02 |
| Joseph Gilliam | Class III director | Appointed | 2026-11-02 |
| Ansuman Satpathy | Class III director | Appointed | 2026-11-02 |
| Randy Wu | General Counsel and Secretary | Appointed | 2025-11-14 |
| Mathai Mammen | member of the Board of Directors | Resigned | 2024-10-29 |
| Justin J. McAnear | Chief Financial Officer | Resigned | 2024-08-08 |
| Mennah Moustafa | Chief Commercial Officer | Appointed | 2024-08-08 |
| Adam S. Taich | Chief Financial Officer | Appointed | 2024-08-08 |
| Sarah A. Teichmann | Class II director | Appointed | 2024-07-11 |
| Alan V. Mateo | Class II director | Appointed | 2024-06-20 |
| Kimberly J. Popovits | member of the Audit Committee | Appointed | 2023-07-20 |
| Bryan E. Roberts | member of the Board of Directors | Resigned | 2023-07-20 |
Leadership
- Serge Saxonov CEO, Board Member
- John R. Stuelpnagel Chairman, Board Member
- Mr. Gilliam Chairman
- Adam S. Taich CFO
- Randy Wu General Counsel
- Alan Mateo Board Member
- Alan V. Mateo Board Member
- Ansuman Satpathy Board Member
- Benjamin J. Hindson Board Member
- Joseph Gilliam Board Member
- Kimberly J. Popovits Board Member
- Sarah A. Teichmann Board Member
- Sarah Teichmann Board Member
- Shehnaaz Suliman Board Member
- Sri Kosaraju Board Member
Key facts
CIK
1770787
CUSIP
88025U109
13F (30d)
378 filings
343 filers
Visit website
Investor relations